Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • Hospitals & Diagnostics
    • Aster DM Healthcare...

    Aster DM Healthcare raises Rs 294 crore from anchor investors

    Written by Ruby Khatun Khatun Published On 2018-02-12T10:45:19+05:30  |  Updated On 16 Aug 2021 4:00 PM IST

    New Delhi: Aster DM Healthcare has raised Rs 294 crore from anchor investors ahead of its initial public offer opening today.


    The company, which runs hospitals in India and the Middle East, has allocated shares to anchor investors at the upper end of the IPO price band of Rs 190 per scrip.






    The price band for the offer, which would be open from February 12 to 15, is Rs 180-190 per share. According to a filing to the stock exchanges, Aster has alloted 1,54,75,843 shares at the price of Rs 190 apiece to anchor investors raising Rs 294 crore.

    First State Indian Subcontinent Fund, SBI Magnum Taxgain Scheme, Karst Peak S Asia Master Fund and Societe Generale are among the anchor investors. Through the IPO, Aster is expected to garner Rs 980 crore.

    The offer comprises fresh issue of equity shares worth up to Rs 725 crore and an offer for sale of up to 1,34,28,251 scrips by the company's promoter Union Investments. Proceeds of the issue would be used towards repayment of debt, purchase of medical equipment, and for other general corporate purposes.

    Kotak Mahindra Capital Company, Axis Capital and Goldman Sachs (India) Securities, ICICI Securities, JM Financial and Yes Securities will manage the company's public issue. The shares are proposed to be listed on BSE and NSE.

    Aster operates in India, the Philippines, Jordan and all the GCC (Gulf Cooperation Council) states comprising the United Arab Emirates, Oman, Saudi Arabia, Qatar, Kuwait, and Bahrain.

    anchor investorsAsterAster DMAster DM HealthcareAxis CapitalfundGoldman Sachshospitalsinitial public offerInvestmentIPOKotak Mahindra Capitalmedical equipmentRaisesSBI Magnum Taxgain Scheme
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok